Article info

PDF

Short report
Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?

Authors

  • Agostina Stradella Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, SpainMedical Oncology Department, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Jesús del Valle Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain PubMed articlesGoogle scholar articles
  • Paula Rofes Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Lídia Feliubadaló Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Èlia Grau Garces Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Àngela Velasco Hereditary Cancer Program, Catalan Institute of Oncology, IDIBGI, Girona, Spain PubMed articlesGoogle scholar articles
  • Sara González Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Gardenia Vargas Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Ángel Izquierdo Hereditary Cancer Program, Catalan Institute of Oncology, IDIBGI, Girona, Spain PubMed articlesGoogle scholar articles
  • Olga Campos Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Eva Tornero Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Matilde Navarro Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Judith Balmaña-Gelpi High Risk and Cancer Prevention Unit, Medical Oncology Department, University Hospital Vall d’Hebron and Vall d’Hebron Institute of Oncology, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Gabriel Capellá Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Marta Pineda Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Joan Brunet Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainHereditary Cancer Program, Catalan Institute of Oncology, IDIBGI, Girona, SpainMedical Sciences Department, School of Medicine, University of Girona, Girona, Spain PubMed articlesGoogle scholar articles
  • Conxi Lázaro Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, SpainCentro de Investigación Biomédica en RED (CIBERONC), Instituto de Salud Carlos III, Madrid, SpainProgram in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Joan Brunet and Dr Conxi Lázaro, Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona 08907, Spain; jbrunet{at}iconcologia.net, clazaro{at}iconcologia.net
View Full Text

Citation

Stradella A, del Valle J, Rofes P, et al
Does multilocus inherited neoplasia alleles syndrome have severe clinical expression?

Publication history

  • Received September 3, 2018
  • Revised October 24, 2018
  • Accepted October 28, 2018
  • First published December 22, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.